Correlation Between PaxMedica, Common and Virios Therapeutics
Can any of the company-specific risk be diversified away by investing in both PaxMedica, Common and Virios Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PaxMedica, Common and Virios Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PaxMedica, Common Stock and Virios Therapeutics Llc, you can compare the effects of market volatilities on PaxMedica, Common and Virios Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PaxMedica, Common with a short position of Virios Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PaxMedica, Common and Virios Therapeutics.
Diversification Opportunities for PaxMedica, Common and Virios Therapeutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between PaxMedica, and Virios is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding PaxMedica, Common Stock and Virios Therapeutics Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virios Therapeutics Llc and PaxMedica, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PaxMedica, Common Stock are associated (or correlated) with Virios Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virios Therapeutics Llc has no effect on the direction of PaxMedica, Common i.e., PaxMedica, Common and Virios Therapeutics go up and down completely randomly.
Pair Corralation between PaxMedica, Common and Virios Therapeutics
Given the investment horizon of 90 days PaxMedica, Common Stock is expected to under-perform the Virios Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, PaxMedica, Common Stock is 1.84 times less risky than Virios Therapeutics. The pink sheet trades about -0.18 of its potential returns per unit of risk. The Virios Therapeutics Llc is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 2,288 in Virios Therapeutics Llc on August 29, 2024 and sell it today you would lose (1,893) from holding Virios Therapeutics Llc or give up 82.74% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 14.67% |
Values | Daily Returns |
PaxMedica, Common Stock vs. Virios Therapeutics Llc
Performance |
Timeline |
PaxMedica, Common Stock |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Virios Therapeutics Llc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Weak
PaxMedica, Common and Virios Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with PaxMedica, Common and Virios Therapeutics
The main advantage of trading using opposite PaxMedica, Common and Virios Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PaxMedica, Common position performs unexpectedly, Virios Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virios Therapeutics will offset losses from the drop in Virios Therapeutics' long position.PaxMedica, Common vs. Quoin Pharmaceuticals Ltd | PaxMedica, Common vs. Revelation Biosciences | PaxMedica, Common vs. Unicycive Therapeutics | PaxMedica, Common vs. Cardio Diagnostics Holdings |
Virios Therapeutics vs. LMF Acquisition Opportunities | Virios Therapeutics vs. ZyVersa Therapeutics | Virios Therapeutics vs. Sonnet Biotherapeutics Holdings | Virios Therapeutics vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |